nursing process - Nursing Case Study

Pathophysiology

• Primary mechanism: Inflammation - Initiation of the inflammatory response is crucial as it leads to the recruitment of immune cells and release of cytokines, causing tissue swelling and redness, impacting cellular function and homeostasis.

• Secondary mechanism: Vascular changes - Vasodilation and increased vascular permeability occur, allowing immune cells to reach the affected area, but also causing fluid leakage into tissues, leading to edema and impaired nutrient exchange.

• Key complication: Tissue damage - Prolonged or excessive inflammation can result in cellular injury or necrosis, compromising organ function and potentially leading to systemic complications, such as sepsis if the inflammatory response becomes widespread.

Patient Profile

Demographics:

52-year-old female, school teacher

History:

• Hypertension, Type 2 Diabetes, Hyperlipidemia

• Metformin 500 mg twice daily, Lisinopril 20 mg once daily, Atorvastatin 10 mg once daily

• Allergic to penicillin

Current Presentation:

• Chief complaint: Shortness of breath and chest tightness

• Key symptoms: Fatigue, intermittent dizziness, mild peripheral edema

• Vital signs: Blood pressure 145/90 mmHg, heart rate 110 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F, oxygen saturation 92% on room air

Section 1

New Diagnostic Results:

As part of the continued assessment, the healthcare team orders a series of diagnostic tests to further evaluate the patient's condition. The results reveal significant findings that require careful interpretation. A chest X-ray shows mild pulmonary congestion, suggestive of early heart failure, likely exacerbated by her underlying hypertension and type 2 diabetes. The echocardiogram indicates reduced ejection fraction at 45%, confirming left ventricular systolic dysfunction. These findings align with her symptoms of shortness of breath, mild peripheral edema, and fatigue, indicating that her heart is not effectively pumping blood, leading to fluid accumulation.

Lab results further support these findings. Her B-type Natriuretic Peptide (BNP) level is elevated at 350 pg/mL, indicating increased cardiac stress. Additionally, the basic metabolic panel reveals an elevated blood glucose level of 180 mg/dL, despite her current treatment regimen, suggesting inadequate glycemic control. Her renal function tests show a slight increase in serum creatinine to 1.4 mg/dL, raising concerns about potential renal involvement due to her long-standing diabetes and hypertension. This constellation of findings points towards the need for a comprehensive reassessment of her treatment plan, emphasizing the importance of optimizing her cardiovascular and metabolic management to prevent further complications.

These diagnostic results provide a clearer picture of the patient's condition, offering several clinical reasoning opportunities. The healthcare team must consider adjusting her medications, potentially adding a diuretic to address fluid overload and reassessing her antidiabetic regimen to improve glucose control. The results underscore the interaction between her chronic conditions and the current inflammatory response, highlighting the need for an integrated approach to managing her complex health issues. The team must also remain vigilant for any signs of deterioration, such as worsening shortness of breath or increased edema, which could indicate further cardiac decompensation or the onset of additional complications. This sets the stage for the next steps in her care journey, focusing on targeted interventions and close monitoring.

Section 2

Change in Patient Status:

Following the adjustments to the patient's treatment plan, including the introduction of a low-dose diuretic and modifications to her antidiabetic regimen, the healthcare team closely monitors her response. Initially, there is a modest improvement in her symptoms; her shortness of breath decreases slightly, and her peripheral edema shows slight regression. However, over the next 48 hours, the patient begins to exhibit new symptoms, including increased fatigue and mild confusion, which prompts immediate reassessment.

Vital signs indicate a slight drop in blood pressure to 98/60 mmHg and a heart rate that remains slightly elevated at 92 beats per minute. Her respiratory rate is stable at 18 breaths per minute, but oxygen saturation has decreased to 91% on room air, suggesting potential respiratory compromise. Repeat lab tests reveal an increase in serum creatinine to 1.6 mg/dL, raising further concerns about her renal function. The blood glucose level remains elevated at 170 mg/dL, despite the adjustments in her diabetes management. These changes suggest an evolving picture of potential acute kidney injury, possibly exacerbated by the recent diuretic therapy, and persistent inadequate glycemic control.

In light of these developments, the healthcare team must employ clinical reasoning to address her altered status. The team considers the interplay of her cardiovascular, renal, and metabolic issues, recognizing the need to balance the management of fluid overload against the risk of worsening renal function. A critical decision involves possibly adjusting her diuretic dosage or exploring alternative medications that may better support her renal function while still alleviating her cardiac symptoms. Additionally, the team must reassess her diabetes management, perhaps involving an endocrinologist to optimize her glycemic control further. This evolving situation underscores the complexity of her condition and the necessity for ongoing vigilance and adaptability in her care strategy, setting the stage for the next phase of her treatment journey.

Section 3

As the healthcare team continues to monitor the patient, a further change in her status is observed over the next 24 hours. Her fatigue and confusion have worsened, indicating a potential neurological impact that necessitates immediate attention. The patient now presents with a noticeable decrease in her level of consciousness, fluctuating between drowsiness and difficulty maintaining attention during conversation. Her blood pressure has dropped further to 92/58 mmHg, and her heart rate has risen to 98 beats per minute. The oxygen saturation remains concerning at 89% on room air, prompting the initiation of supplemental oxygen. Her respiratory rate is slightly increased at 20 breaths per minute, highlighting a possible compensatory mechanism in response to reduced oxygenation.

New diagnostic results reveal a further increase in serum creatinine to 2.0 mg/dL, confirming an acute kidney injury that is likely contributing to her altered mental status and hemodynamic instability. Electrolyte imbalances are apparent, with hyperkalemia noted at 5.5 mmol/L, which may be a consequence of both the renal impairment and the diuretic therapy. Her blood glucose level persists at 180 mg/dL, showing persistent challenges in achieving glycemic control. A chest X-ray is performed to assess for pulmonary congestion, given her respiratory symptoms, and reveals mild pulmonary edema, indicating that fluid management remains suboptimal.

These findings necessitate a reassessment of her treatment plan. The healthcare team must carefully balance fluid management to address her cardiac and renal issues, potentially adjusting the diuretic or considering alternative therapies like ACE inhibitors, which may offer renal protection. Additionally, addressing her hyperkalemia is critical to prevent cardiac complications, possibly requiring dietary modifications, medication adjustments, or even temporary dialysis support. The interplay between her cardiovascular, renal, and metabolic conditions requires a nuanced approach to stabilize her condition, underscoring the need for interdisciplinary collaboration and continuous monitoring. This evolving scenario sets the stage for further intervention strategies and highlights the importance of adapting care to the patient’s complex and changing needs.

Section 4

The healthcare team decides to focus on addressing the patient's hyperkalemia and potential cardiac complications. As part of the immediate intervention, the patient is administered intravenous calcium gluconate to stabilize the cardiac membrane, followed by insulin and glucose to facilitate the intracellular shift of potassium. Additionally, sodium polystyrene sulfonate is considered to promote potassium excretion through the gastrointestinal tract. The interdisciplinary team, including nephrology and cardiology, discusses the possibility of initiating temporary dialysis if these measures do not lead to adequate potassium reduction.

Within hours of these interventions, the patient's heart rate begins to stabilize, dropping slightly to 92 beats per minute, and her blood pressure improves marginally to 98/64 mmHg. However, her oxygen saturation remains at 91% despite supplemental oxygen, indicating persistent respiratory distress. Her level of consciousness shows slight improvement; she is now able to maintain attention during brief interactions, although she remains drowsy. The nursing team continues to monitor her neurological status closely, aware that ongoing hypoxia and electrolyte imbalances could exacerbate her confusion or lead to further complications.

The latest laboratory results show a decrease in serum potassium to 4.8 mmol/L, indicating a positive response to the treatment. However, her renal function continues to be a concern, with serum creatinine remaining elevated at 2.1 mg/dL. The team decides to cautiously adjust her diuretic therapy, prioritizing the prevention of fluid overload and further renal injury. As the patient’s condition remains precarious, the healthcare team emphasizes the importance of vigilant monitoring and rapid response to any changes in her status. This approach underscores the complexity of her case, necessitating ongoing evaluation and adaptation of her care plan as she progresses through her recovery.

Section 5

As the interdisciplinary team continues to monitor the patient, a new complication arises. The patient begins to exhibit signs of gastrointestinal distress, with reports of nausea and intermittent abdominal cramping. Upon further assessment, the nursing team notes hypoactive bowel sounds and mild abdominal distension. These symptoms raise concerns regarding the administration of sodium polystyrene sulfonate, which can lead to gastrointestinal side effects, including constipation and potential bowel obstruction. The patient's electrolyte levels are reassessed, and although her potassium remains stable at 4.8 mmol/L, her sodium levels are slightly elevated at 146 mmol/L, prompting the team to reconsider her electrolyte management strategy.

In response to these developments, the healthcare team decides to temporarily discontinue the sodium polystyrene sulfonate and monitor the patient for any progression of gastrointestinal symptoms. They initiate a gentle hydration protocol with isotonic fluids to help address her elevated sodium levels while being cautious of her renal status. The nephrology consultant emphasizes the importance of maintaining adequate urine output to prevent further complications. The patient's urine output is closely monitored, revealing a slightly reduced volume of 25 mL/hour over the past few hours, indicating potential prerenal azotemia.

As the team evaluates the impact of these interventions, they also focus on the patient's respiratory status, which continues to be a concern. Her oxygen saturation remains suboptimal at 92%, and arterial blood gas analysis reveals a slight respiratory alkalosis with a pH of 7.47, PaCO2 of 33 mmHg, and bicarbonate of 22 mmol/L. These findings suggest possible hyperventilation, likely in response to her underlying distress and electrolyte imbalances. The respiratory therapist adjusts her oxygen delivery to improve oxygenation while minimizing the risk of oxygen toxicity. The team remains vigilant, aware that these interconnected issues require a delicate balance and continuous reassessment to optimize the patient's recovery and prevent further complications.